vs
Karyopharm Therapeutics Inc.（KPTI）与万物新生（RERE）财务数据对比。点击上方公司名可切换其他公司
万物新生的季度营收约是Karyopharm Therapeutics Inc.的1.3倍（$43.2M vs $34.1M），万物新生净利率更高（16.9% vs -299.9%，领先316.8%）
万物新生集团（ATRenew Inc.）是中国领先的二手消费电子产品交易与服务平台运营商，核心业务覆盖数码产品回收、质检、翻新及售卖，运营有爱回收等知名品牌，服务覆盖个人消费者及企业客户，市场遍及国内及部分东南亚地区。
KPTI vs RERE — 直观对比
营收规模更大
RERE
是对方的1.3倍
$34.1M
净利率更高
RERE
高出316.8%
-299.9%
损益表 — Q4 FY2025 vs Q1 FY2023
| 指标 | | |
|---|---|---|
| 营收 | $34.1M | $43.2M |
| 净利润 | $-102.2M | $7.3M |
| 毛利率 | — | — |
| 营业利润率 | -52.4% | — |
| 净利率 | -299.9% | 16.9% |
| 营收同比 | 11.6% | — |
| 净利润同比 | -232.0% | — |
| 每股收益（稀释后） | $-7.02 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KPTIRERE
| Q4 25 | $34.1M | — | ||
| Q3 25 | $44.0M | — | ||
| Q2 25 | $37.9M | — | ||
| Q1 25 | $30.0M | — | ||
| Q4 24 | $30.5M | — | ||
| Q3 24 | $38.8M | — | ||
| Q2 24 | $42.8M | — | ||
| Q1 24 | $33.1M | — |
净利润KPTIRERE
| Q4 25 | $-102.2M | — | ||
| Q3 25 | $-33.1M | — | ||
| Q2 25 | $-37.3M | — | ||
| Q1 25 | $-23.5M | — | ||
| Q4 24 | $-30.8M | — | ||
| Q3 24 | $-32.1M | — | ||
| Q2 24 | $23.8M | — | ||
| Q1 24 | $-37.4M | — |
营业利润率KPTIRERE
| Q4 25 | -52.4% | — | ||
| Q3 25 | -34.6% | — | ||
| Q2 25 | -64.3% | — | ||
| Q1 25 | -110.8% | — | ||
| Q4 24 | -102.4% | — | ||
| Q3 24 | -67.8% | — | ||
| Q2 24 | -65.7% | — | ||
| Q1 24 | -101.9% | — |
净利率KPTIRERE
| Q4 25 | -299.9% | — | ||
| Q3 25 | -75.2% | — | ||
| Q2 25 | -98.2% | — | ||
| Q1 25 | -78.2% | — | ||
| Q4 24 | -100.8% | — | ||
| Q3 24 | -82.7% | — | ||
| Q2 24 | 55.6% | — | ||
| Q1 24 | -112.8% | — |
每股收益（稀释后）KPTIRERE
| Q4 25 | $-7.02 | — | ||
| Q3 25 | $-3.82 | — | ||
| Q2 25 | $-4.32 | — | ||
| Q1 25 | $-2.77 | — | ||
| Q4 24 | $-2.33 | — | ||
| Q3 24 | $-3.85 | — | ||
| Q2 24 | $-2.97 | — | ||
| Q1 24 | $-4.85 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $60.5M | $228.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-292.9M | $557.1M |
| 总资产 | $108.4M | $722.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KPTIRERE
| Q4 25 | $60.5M | — | ||
| Q3 25 | $37.7M | — | ||
| Q2 25 | $38.7M | — | ||
| Q1 25 | $38.8M | — | ||
| Q4 24 | $62.5M | — | ||
| Q3 24 | $72.8M | — | ||
| Q2 24 | $84.8M | — | ||
| Q1 24 | $30.6M | — |
股东权益KPTIRERE
| Q4 25 | $-292.9M | — | ||
| Q3 25 | $-269.3M | — | ||
| Q2 25 | $-238.9M | — | ||
| Q1 25 | $-205.9M | — | ||
| Q4 24 | $-186.0M | — | ||
| Q3 24 | $-159.6M | — | ||
| Q2 24 | $-132.1M | — | ||
| Q1 24 | $-169.0M | — |
总资产KPTIRERE
| Q4 25 | $108.4M | — | ||
| Q3 25 | $96.2M | — | ||
| Q2 25 | $104.9M | — | ||
| Q1 25 | $127.7M | — | ||
| Q4 24 | $164.4M | — | ||
| Q3 24 | $189.5M | — | ||
| Q2 24 | $214.0M | — | ||
| Q1 24 | $204.5M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-11.8M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流KPTIRERE
| Q4 25 | $-11.8M | — | ||
| Q3 25 | $-5.9M | — | ||
| Q2 25 | $-18.7M | — | ||
| Q1 25 | $-39.0M | — | ||
| Q4 24 | $-25.8M | — | ||
| Q3 24 | $-19.5M | — | ||
| Q2 24 | $-38.5M | — | ||
| Q1 24 | $-43.7M | — |
自由现金流KPTIRERE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-25.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-43.9M | — |
自由现金流率KPTIRERE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -84.7% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -132.6% | — |
资本支出强度KPTIRERE
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.6% | — |
现金转化率KPTIRERE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.62× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KPTI
| Products | $32.1M | 94% |
| License And Other | $2.0M | 6% |
RERE
暂无分部数据
